Publication:
The diagnostic utility of maspin in the distinction between malignant mesothelioma and pulmonary adenocarcinoma

dc.contributor.authorÖz, Büge Türkili
dc.contributor.authorDemir, Hale
dc.contributor.buuauthorAkyıldız, Elif Ülker
dc.contributor.buuauthorŞehitoğlu, İbrahim
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıbbi Patoloji Ana Bilim Dalı
dc.contributor.researcheridABF-8955-2021
dc.contributor.scopusid55901306600
dc.contributor.scopusid36553239400
dc.date.accessioned2022-07-01T10:40:25Z
dc.date.available2022-07-01T10:40:25Z
dc.date.issued2010
dc.description.abstractImmunohistochemistry is frequently employed to differentiate between malignant mesothelioma (MM) and pulmonary adenocarcinoma (AC) infiltrating the pleura, but there is uncertainty as to which antibodies are most useful. The present study investigated the presence of the serine protease, maspin, in epithelioid MMs and evaluated the diagnostic utility of maspin for the differential diagnosis between epithelioid MM and pulmonary AC with pleural involvement. The results showed more frequent maspin immunostaining among AC cases compared with MM cases. Maspin positivity was significantly higher among AC cases with respect to both the extent and intensity of staining. A significant difference also existed between the two tumour types with respect to the overall maspin score. Despite these findings, the sensitivity and specificity of maspin positivity to detect AC were only 59% and 73%, respectively, indicating that detection of maspin is of no value for the differential diagnosis of AC and MM.
dc.identifier.citationAkyıldız, E. Ü. vd. (2010). "The diagnostic utility of maspin in the distinction between malignant mesothelioma and pulmonary adenocarcinoma". Journal of International Medical Research, 38(3), 1070-1076.
dc.identifier.endpage1076
dc.identifier.issn0300-0605
dc.identifier.issue3
dc.identifier.pubmed20819444
dc.identifier.scopus2-s2.0-77954792694
dc.identifier.startpage1070
dc.identifier.urihttps://doi.org/10.1177/147323001003800334
dc.identifier.urihttps://journals.sagepub.com/doi/10.1177/147323001003800334?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
dc.identifier.urihttp://hdl.handle.net/11452/27596
dc.identifier.volume38
dc.identifier.wos000280677800035
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherSage Publications
dc.relation.collaborationYurt içi
dc.relation.journalJournal of International Medical Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMalignant mesothelioma
dc.subjectPulmonary adenocarcinoma
dc.subjectMaspin
dc.subjectImmunohistochemistry
dc.subjectExpression
dc.subjectTumor-suppressor gene
dc.subjectCell lung-cancer
dc.subjectEpithelioid mesothelioma
dc.subjectImmunohistochemical diagnosis
dc.subjectPrognostic-significance
dc.subjectAntibodies
dc.subjectCarcinoma
dc.subjectMammary
dc.subjectUpdate
dc.subjectResearch & experimental medicine
dc.subjectPharmacology & pharmacy
dc.subject.emtreeMaspin
dc.subject.emtreeSerine proteinase
dc.subject.emtreeSerine proteinase inhibitor
dc.subject.emtreeSERPIN-B5
dc.subject.emtreeTumor marker
dc.subject.emtreeAdult
dc.subject.emtreeAged
dc.subject.emtreeArticle
dc.subject.emtreeClinical evaluation
dc.subject.emtreeControlled study
dc.subject.emtreeDiagnostic value
dc.subject.emtreeDifferential diagnosis
dc.subject.emtreeEpithelioid cell
dc.subject.emtreeFemale
dc.subject.emtreeGene expression
dc.subject.emtreeHuman
dc.subject.emtreeHuman cell
dc.subject.emtreeHuman tissue
dc.subject.emtreeImmunohistochemistr
dc.subject.emtreeLung adenocarcinoma
dc.subject.emtreeMale
dc.subject.emtreeMalignant mesothelioma
dc.subject.emtreeProtein determination
dc.subject.emtreeProtein expression
dc.subject.emtreeSensitivity and specificity
dc.subject.emtreeAdenocarcinoma
dc.subject.emtreeChemistry
dc.subject.emtreeEnzyme immunoassay
dc.subject.emtreeEvaluation study
dc.subject.emtreeLung neoplasms
dc.subject.emtreeMesothelioma
dc.subject.emtreeMiddle aged
dc.subject.emtreeNeoplasms, mesothelial
dc.subject.emtreePredictive value
dc.subject.emtreeSecondary
dc.subject.meshAdenocarcinoma
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshDiagnosis, differential
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshImmunoenzyme techniques
dc.subject.meshLung neoplasms
dc.subject.meshMale
dc.subject.meshMesothelioma
dc.subject.meshMiddle aged
dc.subject.meshNeoplasms, mesothelial
dc.subject.meshPredictive value of tests
dc.subject.meshSerine proteinase inhibitors
dc.subject.meshSerpins
dc.subject.meshTumor markers, biological
dc.subject.scopusSERPIN-b5; Serine Proteinase Inhibitors; Serpins
dc.subject.wosMedicine, research & experimental
dc.subject.wosPharmacology & pharmacy
dc.titleThe diagnostic utility of maspin in the distinction between malignant mesothelioma and pulmonary adenocarcinoma
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Tıbbi Patoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: